“To have the opportunity to test for the more common EGFR mutations at the same time is highly clinically relevant for us.” Simultaneous tests and multiple detections The dPCR technology that ...

Activating mutations in EGFR are characteristic of patients with ... While this study was designed to test non-inferiority of gefitinib as measured by PFS, it also included a pre-defined threshold ...